It’s not ‘just a tube of blood’: principles of protocol development, sample collection, staffing and budget considerations for blood-based biomarkers in immunotherapy studies

Immunotherapy for cancer is now a standard pillar in the armamentarium of treatments for many cancers. Immune checkpoint inhibitors, in particular, have resulted in significant therapeutic benefit and prolongation of survival in solid organ cancers, such as melanoma and lung cancer. However, the ext...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Cindy Y, Niu, Zeqi, Green, Michael D, Zhao, Lili, Raupp, Shelby, Pannecouk, Brittany, Brenner, Dean E, Nagrath, Sunitha, Ramnath, Nithya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320252/
https://www.ncbi.nlm.nih.gov/pubmed/34321277
http://dx.doi.org/10.1136/jitc-2021-003212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320252/
https://www.ncbi.nlm.nih.gov/pubmed/34321277
http://dx.doi.org/10.1136/jitc-2021-003212

Ejemplares similares